Thursday, May 8, 2014

Kallo, Inc. (KALO) Full-Spectrum Healthcare Information Technology and Tailored Infrastructure Solutions Primed for Explosive Global Growth

Kallo has put together an advanced suite of medical technology offerings that vastly improve quality and efficiency of healthcare delivery, with products ranging from health informatics solutions like !ntegraat, which integrates with existing medical technologies and allows for the seamless transmission of data off any EMR, PACS, HIS, RIS, PIS or DI-r device, to fully-equipped and telehealth-enabled mobile clinic solutions like MobileCare™, designed to bring the latest, best-in-class medical equipment to remote and unreached communities. The company’s RuralCare™, pre-fabricated, project determined modular solutions, ranging in size from 1.2k to 3.8k square feet, are intended for rapid implementation (as little as one week) of response capability in rural areas or locations hit by a disaster. An ingenious concept capable of bringing the complete architecture of a clinic to bear when and where it is needed, with everything from x-ray and ultrasound machines, to surgical operating rooms, a laboratory, and even a pharmacy.

With total global health expenditure now somewhere over $6.5T according to WHO data (9.3% of GDP on average globally, or 17.7% here in the states during 2011), KALO stands poised to deliver full-spectrum medical technology solutions into an eager market, solutions that are reinforced by cutting edge data and information handling capabilities. The company cuts a rather wide swath in the industry already, addressing critical healthcare and business needs of both healthcare organizations, hospitals, physicians, and Ministries of Health, but the real long-term upside is largely still ahead of KALO and interested investors could really make a killing here while helping to save and enhance lives.

The growing $25B medical tourism industry has been fueled by globalization and reduced costs of travel, as well as mounting pressures on local/regional healthcare systems that produce inordinate wait times for patients or poor quality of care. This revenue-rich market is perfect for solutions like KALO’s CygnaMed™ platform, which enables Ministries of Tourism and Health to promote medical tourism in their country, all within a fully bi-directional software environment that allows for circumspect standardization of clinical processes, as well as constantly evolving/varied protocols for treatment. Such a solution allows for optimum care continuity irrespective of location and the software platform also allows providers to easily make sense of differing pharmacopeia (pharmaceutical drug preparation specs), helping to ameliorate the growing concern over iatrogenic effects linked to patient medications.

The company recently inked a major supply and maintenance contract with the Minister of Health and Public Hygiene of Guinea valued at over $200M for MobileCare and RuralCare deployments in Guinea, with a sweeping public awareness campaign already afoot and emphasis on the rural areas. This is a huge move backed firmly by the President of Guinea himself, Professor Condé, who has made it a priority to get the kind of top-notch healthcare KALO can provide, rapidly out to the people of Guinea. This is the kind of bottom-line driving deal that KALO was created to seize hold of and investors should take note at the underserved global healthcare market (especially in massively underserved regions like Guinea) and the traction possible for the company’s innovative drop-in, full-spectrum healthcare solutions.

The company’s critical medical data integration and dissemination platform Keristaa™ has come into sharper focus recently with the continued spread of the MERS virus in Saudi Arabia and the first U.S. case also having cropping up here in the last few days. Keristaa enables instantaneous monitoring of outbreaks of infectious disease, detecting and indentifying port of entry vulnerabilities and channeling the data directly to relevant CDC and Ministry of Health offices, further maintaining a strict protocol envelope for treatment that is in line with CDC/WHO directives. The May 3 announcement by the Guinea Ministry of Health regarding some 231 suspected and confirmed cases, as well as 155 deaths from the incredibly dangerous Ebola hemorrhagic fever across the country (including in the capital of Conakry), brings into stark contrast the need for such platforms as Keristaa, as well as its efficacy in helping to thwart pandemics. Moreover, it throws a spotlight on the aggressive move by the Guinea government to roll out serious healthcare infrastructure via KALO and the company’s key role in helping to avert a more serious global problem, as the virus has already spread to neighboring Liberia.

KALO’s commitment to developing their far-reaching presence in this space is further reinforced by their oHealth framework, which brings together the requisite technology and training, as well as infrastructure and support, to allow for seamless integration between any kind of clinic, lab or other specialty medical facility, with full leveraging of and communication with any repository or national/regional Health Information Access Layers. The company’s intuitive approach to addressing rising global healthcare demands spells shareholder gold and investors will want to keep an eye on KALO as the company continues to outpace antiquated healthcare implementation models in the still-emerging, developing nations in particular.

More info on Kallo is available at www.KalloInc.ca

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net


Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: